December 02, 2025 a 11:43 am
DXCM: Fundamental Ratio Analysis - DexCom, Inc.
DexCom, Inc. operates in the evolving healthcare sector, focusing on the innovative field of continuous glucose monitoring. The company's stock performance is linked closely to its cutting-edge products and collaborations. With a stable foothold in both domestic and international markets, the potential for growth is visible, though not without risks associated with market competition and technological advancements.
Fundamental Rating
DexCom's fundamental ratings reflect a mixed landscape with impressive returns balanced by issues in equity management and valuation challenges.
| Category | Score | Visualization |
|---|---|---|
| Discounted Cash Flow | 4 | |
| Return On Equity | 5 | |
| Return On Assets | 5 | |
| Debt to Equity | 1 | |
| Price To Earnings | 1 | |
| Price To Book | 1 |
Historical Rating
The historical ratings of DexCom highlight stability in operational scores with consistent outcomes despite shifting market conditions.
| Date | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|
| 2025-12-01 | 3 | 4 | 5 | 5 | 1 | 1 | 1 |
| N/A | 0 | 4 | 5 | 5 | 1 | 1 | 1 |
Analyst Price Targets
Analysts foresee potential where price targets range from approachable to optimistic, though consensus suggests a moderate buy.
| High | Low | Median | Consensus |
|---|---|---|---|
| 99 | 63 | 84 | 83.89 |
Analyst Sentiment
The analyst sentiment indicates strong investor confidence, with a majority leaning towards ‘Buy’ due to the company’s robust innovations and market presence.
| Rating | Count | Visualization |
|---|---|---|
| Strong Buy | 1 | |
| Buy | 40 | |
| Hold | 10 | |
| Sell | 1 | |
| Strong Sell | 0 |
Conclusion
DexCom presents a promising investment opportunity with its cutting-edge product line and strong market presence. While its financial ratios point towards stability in returns, challenges remain in debt management and valuation metrics. The positive analyst sentiment and price targets underscore potential for growth, albeit with awareness for industry competition. As the company advances its technological offerings, it remains a watchful opportunity in the healthcare sector.